ClinicalTrials.Veeva

Menu

Comparison of Low-intensity Extracorporeal Shockwave Therapy and Low-intensity Laser Effects in Adhesive Capsulitis

A

Ahi Evran University Education and Research Hospital

Status

Completed

Conditions

Adhesive Capsulitis

Treatments

Other: Conventional Control Group
Other: Low-intensity ESWT Group
Other: Low-intensity laser Group

Study type

Interventional

Funder types

Other

Identifiers

NCT05689593
AEU-FTR-FE-01

Details and patient eligibility

About

The aim of this study is to compare the effects of extracorporeal shock wave therapy(eswt) applied in addition to conventional physical therapy on pain, mobility, functional ability, sleep quality and activities of daily living in patients with adhesive capsulitis compared to low-level laser therapy and to investigate whether they are superior to the control group.

Full description

In this study, 60 adhesive capsulitis with age range 18-65 who applied to Kırsehir Ahi Evran University Training and Research Hospital were examined.Adhesive capsulitis is also called arthrofibrosis, which involves excessive adhesion formation along the glenohumeral joint. It is a disease of unknown etiology and is classified as primary and secondary. Primary adhesive capsulitis includes cases of idiopathic origin resulting from chronic inflammation with fibroblast proliferation. Secondary adhesive capsulitis, central nervous system involvement, arm immobilized for a long time, trauma or fracture, infectious diseases, etc. Includes post-mortem situations.

Adhesive capsulitis progression is characterized by four stages, each stage presenting a distinctive clinical picture.

low-level laser therapy supports cell proliferation and tissue regeneration with its anti-inflammatory and photobiostimulation properties.The pressure waves of ESWT pass through fluids and soft tissues and exert their effects in areas of impedance change such as bones and soft tissue spaces. These waves have mechanical and cellular effects. The most important of these effects are temporary damage to the neuronal cell membrane or increased permeability. These mechanisms may facilitate neovascularization and cellular regeneration in tissues.

Enrollment

65 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • male and female patients who have received "adhesive capsulitis" by clinical and examination
  • Patients with loss of range of motion in the capsular pattern (external rotation > abduction > internal rotation) will be included in the study.
  • Patients who consent to participate in the study according to the informed consent form will be included in the study.

Exclusion criteria

  • Upper extremity injury in the last 6 months
  • Shoulder injection in the last 6 months
  • Existing open wound in the upper extremity area
  • Prior upper extremity surgery
  • The patient has a systemic infection
  • Uncontrolled hypertension in the patient
  • Inability of the patient to cooperate
  • The patient's unwillingness to participate in the study
  • The patient has a malignancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

65 participants in 3 patient groups

Low-intensity ESWT Group
Active Comparator group
Description:
low intensity extracorporeal shock wave therapy will be applied to patients shoulder, also patients will receive a conventional therapy program consisting of hotpack and exercises
Treatment:
Other: Low-intensity ESWT Group
Other: Conventional Control Group
Low-intensity laser Group
Active Comparator group
Description:
low intensity laser will be applied to patients shoulder, also patients will receive a conventional therapy program consisting of hotpack and exercises
Treatment:
Other: Low-intensity laser Group
Other: Conventional Control Group
Conventional Control Group
Other group
Description:
patients will receive a conventional therapy program consisting of hotpack and exercises
Treatment:
Other: Conventional Control Group

Trial contacts and locations

1

Loading...

Central trial contact

Furkan ERDİNÇ, Ass. Dr.; ismail Ceylan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems